Covidien advises customers about impending molybdenum shortage
Covidien has alerted customers for its technetium-99m generators about impending shortages caused by the unexpected shutdown of the Dutch nuclear reactor that serves as its main source of molybdenum-99.
Covidien has alerted customers for its technetium-99m generators about impending shortages caused by the unexpected shutdown of the Dutch nuclear reactor that serves as its main source of molybdenum-99.
General manager Rick Lytle announced the following changes Aug. 27 to the production schedule for its Ultra-Technekow DTE Tc-99m generator:
- Aug. 31: All standing orders will be filled, but an expected 25% shortfall of MO-99 supply will force the company to reduce generator sizes for all shipments.
- Sept. 1: No shipments will be made on Labor Day.
- Sept. 3: Orders will be filled, but their capacities will be cut to reflect a 50% cut in normal MO-99 availability.
- Sept. 5: No generator orders will be filled.
Covidien depends mainly on the High Flux reactor at Petten in the Netherlands for the production of MO-99 isotope, the precursor isotope to Tc-99m, which is produced as MO-99 decays. The isotope supply chain is susceptible to shortages because of the 66-hour half-life of MO-99.
The Netherlands Energy Research & Consultancy Group announced Aug. 26 that isotope production at the Petten research reactor would cease for at least one month while technicians track down the source of a gas leak between the reactor and the coolant system that was discovered during routine maintenance. Covidien also receives source material from reactors in Europe, Canada, and South Africa. In a written statement, however, the Hazelwood, MO, company said that alternative sources cannot make up for the entire shortfall. The firm is also increasing thallous chloride (TI-201) production as an alternative option for cardiac studies. The company did not disclose how many customers are affected, though they include nuclear medicine facilities in the U.S., Europe, Latin American, Canada, and parts of Asia. For more information from the Diagnostic Imaging archives:
Nuclear medicine braces for effects of Petten reactor shutdown
SNM panel finds no easy path to expand molybdenum-99 supplies
Canadian agency pulls plug on molybdenum reactors
Isotope supply crash drives push for new moly sources
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
